In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans

Abstract excerpt

BACKGROUND: Currently available vaccines against leptospirosis are of low efficacy, have an unacceptable side-effect profile, do not induce long-term protection, and provide no cross-protection against the different serovars of pathogenic leptospira. The current major focus in leptospirosis research is to discover conserved protective antigens that may elicit longer-term protection against a broad range of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Brucella: diagnosis, epidemiology, treatment
• Share to Leptospirosis research and findings
• Share to Syphilis Diagnosis and Treatment